Geistlich Fibro-Gide^® is a porcine, porous, resorbable and volume-stable collagen matrix, specifically designed for soft-tissue regeneration.¹ The collagen matrix is made of reconstituted collagen and undergoes smart chemical cross-linking to improve its volume stability while maintaining a good biocompatibility.^1-3 The porous network of Geistlich Fibro-Gide^® supports angiogenesis, formation of new connective tissue and stability of the collagen network in submerged healing.^2,3 In vivo animal models have shown good integration of Geistlich Fibro-Gide^® into the surrounding soft-tissue while maintaining stability.⁴

Geistlich Fibro-Gide^® is the alternative to autogenous connective tissue grafts (CTG), which are considered as the gold standard in regenerative soft-tissue procedures.^3,5,6 With Geistlich Fibro-Gide^® additional harvest site is avoided, patient morbidity is reduced.^3,7-9

Inspired by Nature, engineered by Geistlich

The collagen expertise of Geistlich has led to a tailor-made product meeting the clinical needs and providing therapeutic solutions in oral soft-tissue regeneration. More than 1,000 prototypes were developed and tested in order to get a product like Geistlich Fibro-Gide^®.¹¹

The product is currently not included in the ARTG. Please contact our customer service team on 1800 776 326 to find out more about accessing Geistlich Fibro-Gide^®

References 

1. Instructions for Use. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland. 
2. Thoma DS. et al. Clin Oral Implants Res. 2015 Mar; 26(3): 263–70.
3. Thoma DS. et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
4. Thoma DS. et al. Clin Oral Implants Res. 2012 Dec; 23(12): 1333–9.
5. Thoma DS. et al. Clin Oral Implants Res. 2009 Sep; 20 Suppl 4: 146–65.
6. Thoma DS. et al. J Clin Periodontol. 2014 Apr; 41 Suppl 15: S77–91.
7. Sanz M. et al. J Clin Periodontol 2009; 36(10): 868-76.
8. Del Pizzo M. et al. J Clin Periodontol. 2002 Sep; 29(9): 848–54.
9. Soileau KM. & Brannon RB. J Periodontol. 2006 Jul; 77(7): 1267–73.
10. Zeltner M. et al. J Clin Periodontol. 2017 Apr; 44(4): 446–453.
11. Data on file. Geistlich Pharma AG, Wolhusen, Switzerland.